Article
Author(s):
The FDA is adding its strongest possible warnings to the drug labeling of prescription opioid pain medications, opioid cough medicines, and benzodiazepines concerning serious adverse effects seen with concomitant use.
The FDA is adding its strongest possible warnings to the drug labeling of prescription opioid pain medications, opioid cough medicines, and benzodiazepines concerning serious adverse effects seen with concomitant use.
In a recent drug safety announcement, the FDA reported that combining opioids with benzodiazepines or other drugs that depress the central nervous system (CNS) can cause life-threatening adverse effects, such as slowed or difficult breathing and death. Past studies have shown a heightened risk of deadly drug overdose with the combined use of these medications. Meanwhile, the FDA conducted 2 studies that uncovered an increasing trend in concomitant dispensing of opioids and benzodiazepines, as well as an increase in combined prescription opioid-benzo abuse, misuse, and overdose.
In light of these findings, the FDA is adding new Boxed Warnings and revising the Warnings and Precautions, Drug Interactions, and Patient Counseling Information sections of both drug classes’ labeling to warn health care professionals and patients about these risks. The agency is also requiring new or revised Medication Guides for patients.
Health care professionals are advised against prescribing opioid cough medications to patients using benzodiazepine or other CNS depressants, including alcohol, and they should only prescribe opioids with benzodiazepines or other CNS depressant medications to patients who have no adequate alternative treatment options. Prescribed combinations of opioid medicines and benzodiazepines should be limited in dosages and duration of each drug to the minimum possible.
Patients and caregivers should be warned about the drugs’ risks and seek immediate medical attention if they experience unusual dizziness or lightheadedness, extreme sleepiness, slowed or difficult breathing, or unresponsiveness while taking these medications.
The FDA is also in the process of evaluating the combined use of benzodiazepine and other CNS depressants with medication-assisted therapy drugs used to treat opioid addiction and dependence, as well as determining whether labeling revisions are necessary for other CNS depressants similar to benzodiazepines. In the meantime, the agency is urging health care professionals and patients to report any adverse effects related to these products to its MedWatch Safety Information and Adverse Event Reporting Program.
Prescription opioids (Table 1) are used to manage pain and treat cough, while benzodiazepines and other CNS depressants (Table 2) are typically used to treat anxiety, insomnia, and seizures.
Table 1: Prescription Opioid Pain and Cough Medicines
Generic Name
Found in Brand Name(s)
alfentanil
Alfenta
buprenorphine
Belbuca, Buprenex, Butrans
butorphanol
No brand name currently marketed
codeine
Fioricet w/ codeine, Fiorinal w/ codeine, Soma Compound w/ codeine, Tylenol w/ codeine, Prometh VC w/ codeine (cough), Triacin-C (cough), Tuzistra-XR (cough)
dihydrocodeine
Synalgos-DC
fentanyl
Abstral, Actiq, Duragesic, Fentora, Ionsys, Lazanda, Sublimaze, Subsys
hydrocodone
Anexsia, Hysingla ER, Lortab, Norco, Reprexain, Vicodin, Vicoprofen, Zohydro ER, Flowtuss (cough), Hycofenix (cough), Obredon (cough), Rezira (cough), Tussicaps (cough), Tussigon (cough), Tussionex Pennkinetic (cough), Vituz (cough), Zutripro (cough)
hydromorphone
Dilaudid, Dilaudid-HP, Exalgo
meperidine
Demerol
methadone
Dolophine
morphine
Astramorph PF, Duramorph PF, Embeda, Infumorph, Kadian, Morphabond, MS Contin
oxycodone
Oxaydo, Oxycet, Oxycontin, Percocet, Percodan, Roxicet, Roxicodone, Xartemis XR
oxymorphone
Opana, Opana ER
pentazocine
Talwin
remifentanil
Ultiva
sufentanil
Sufenta
tapentadol
Nucynta, Nucynta ER
tramadol
Conzip, Ultracet, Ultram, Ultram ER
Table 2: Benzodiazepines and Other CNS Depressants
Generic Name
Brand Name(s)
Benzodiazepines
alprazolam
Xanax, Xanax XR
chlordiazepoxide
Librium, Librax
clobazam
Onfi
clonazepam
Klonopin
clorazepate
Gen-Xene, Tranxene
diazepam
Diastat, Diastat Acudial, Valium
estazolam
No brand name currently marketed
flurazepam
No brand name currently marketed
lorazepam
Ativan
oxazepam
No brand name currently marketed
quazepam
Doral
temazepam
Restoril
triazolam
Halcion
Other Sleep Drugs and Tranquilizers
butabarbital sodium
Butisol
eszopiclone
Lunesta
pentobarbital
Nembutal
ramelteon
Rozerem
secobarbital sodium
Seconal sodium
suvorexant
Belsomra
zaleplon
Sonata
zolpidem
Ambien, Ambien CR, Edluar, Intermezzo, Zolpimist
Muscle Relaxants
baclofen
Gablofen, Lioresal
carisoprodol
Soma, Soma Compound, Soma Compound w/ codeine
chlorzoxazone
No brand name currently marketed
cyclobenzaprine
Amrix
dantrolene
Dantrium, Revonto, Ryanodex
metaxalone
Skelaxin
methocarbamol
Robaxin, Robaxin-750
orphenadrine
No brand name currently marketed
tizanidine
Zanaflex
Antipsychotics
aripiprazole
Abilify, Abilify Maintena, Aristada
asenapine
Saphris
cariprazine
Vraylar
chlorpromazine
No brand name currently marketed
clozapine
Clozaril, Fazaclo ODT, Versacloz
fluphenazine
No brand name currently marketed
haloperidol
Haldol
iloperidone
Fanapt
loxapine
Adasuve
lurasidone
Latuda
molindone
No brand name currently marketed
olanzapine
Symbyax, Zyprexa, Zyprexa Relprevv, Zyprexa Zydis
paliperidone
Invega, Invega Sustenna, Invega Trinza
perphenazine
No brand name currently marketed
pimavanserin
Nuplazid
quetiapine
Seroquel, Seroquel XR
risperidone
Risperdal, Risperdal Consta
thioridazine
No brand name currently marketed
thiothixene
Navane
trifluoperazine
No brand name currently marketed
ziprasidone
Geodon
*This is not a comprehensive list.